美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
LAMIVUDINE; ZIDOVUDINE	021943	001	NDA	LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	TABLET; ORAL	150MG; 300MG; 600MG	No	No	2006/03/06 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE; ABACAVIR	021944	001	NDA	LAMIVUDINE; ZIDOVUDINE; ABACAVIR	TABLET; ORAL	150MG; 300MG; 300MG	No	No	2006/07/26 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE	021971	001	NDA	LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE	TABLET; ORAL	150MG; 300MG; 200MG	No	No	2007/01/31 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	022096	001	NDA	LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	TABLET; ORAL	150MG; 300MG; 600MG	No	No	2007/06/01 (TA)	--	STRIDES ACROLAB	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	078929	001	ANDA	LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL	150MG; 300MG	No	No	2007/08/08 (TA)	--	EMCURE PHARMA	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	022296	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL	30MG; 60MG	No	No	2009/07/23 (TA)	--	AUROBINDO PHARMA LTD	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	200748	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL	30MG; 60MG	No	No	2011/01/05 (TA)	--	MATRIX LABS LTD	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	201151	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL	30MG; 60MG	No	No	2011/09/22 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	202814	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET, FOR SUSPENSION; ORAL	30MG; 60MG	No	No	2012/06/15 (TA)	--	CIPLA LIMITED	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE	204914	001	NDA	LAMIVUDINE; ZIDOVUDINE	TABLET; ORAL SUSPENSION	30MG; 60MG	No	No	2014/02/04 (TA)	--	MYLAN LABS	None (Tentative Approval)
LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ	206040	001	NDA	LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ	TABLET;ORAL	150MG;300MG;600MG	No	No	2014/09/04 (TA)	--	MYLAN LABS LTD	None (Tentative Approval)